VIR Latest Press Releases

-- August 31, 2026 --

Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Business Wire 4:05 PM

-- August 5, 2026 --

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results Business Wire 4:05 PM

-- July 24, 2026 --

Vir Biotechnology Announces Chief Financial Officer Transition Business Wire 8:30 AM

-- July 22, 2026 --

Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results Business Wire 4:05 PM

-- June 10, 2026 --

Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors Business Wire 4:05 PM

-- May 18, 2026 --

Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026 Business Wire 4:05 PM

-- May 14, 2026 --

"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies Globe Newswire 10:55 AM

-- May 6, 2026 --

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results Business Wire 4:05 PM

-- May 5, 2026 --

Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference Business Wire 4:05 PM

-- April 23, 2026 --

Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results Business Wire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software